Coronavirus Update: The FDA’s decision on Novavax’s COVID-19 vaccine could come in weeks
Marketwatch - 2022-05-26T15:15:00.000Z

The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore.

Read this story at Marketwatch